Technology

March 16, 2015.

March 12. 2015.

March 12, 2015.

March 11, 2015.

March 11, 2015.

March 10, 2015.

March 6, 2015.

6 March, 2015.

March 5, 2015.

March 3, 2015.

March 3, 2015.

February 26, 2015.

23 February, 2015.

23 February, 2015.

February 19, 2015.

February 18, 2015.

February 17, 2015.

February 17, 2015.

Astellas Pharma announced that the company will now make trial data available through an independent website that enables researchers to request and access clinical trial data.

Pfizer announced on Feb. 5, 2015 that it is acquiring injectable, infusible, and biosimilar manufacturer Hospira for nearly $17 billion after the assumption of debt.

The pharma, medical and biotech sector accounted for the top three announced deals of the year in the EMEA region in 2014.

The French pharmaceutical market is forecast to grow at a "tepid" CAGR of 0.7% from $46.2 billion in 2014 to $48.2 billion by 2020, according to GlobalData.

Pharma and healthcare are among the many areas being viewed with increasing attention inside and outside Greece, following the victory in the country’s elections of the radical left-wing, anti-austerity Syriza party.

AstraZeneca (AZ) and The University of Texas MD Anderson Cancer Center (Houston, TX) have announced a multi-year, strategic research collaboration.

Findings from the joint report on the occurrence of antimicrobial resistance in bacteria from humans and food-producing animals.

The European Hantavirus diagnostics market is growing at a CAGR of 5.8 percent, outperforming the U.S. market, which registered 3.7 percent.

GlaxoSmithKline (GSK) announced on January 26 that it will freeze vaccine prices for Gavi-eligible countries for up to 10 years after the country graduates from Gavi support.

Bill Drummy presents the highlights (what he will admit to, anyway) from this month's International Consumer Electronics Show in Las Vegas.

Glaxo SmithKline (GSK) has announced that Sir Philip Hampton has been appointed Chairman of the Nominations Committee, effective today (January 27).

Franz Humer, former CEO and chairman of Roche, has joined BIAL, Portugal's largest pharma company, as a non-executive board member.